(Finance) – With reference to the voluntary public purchase offer (OPA) on all the shares Kolinpharmaa company operating in the nutraceutical sector and listed on the Euronext Growth Milan market, it appears that as of September 1st, 3,800 shares had been subscribed to the sell-out procedure. These shares are equal to 2.934% of the remaining shares and 0.232% of the entire share capital.
The sell-out period started on August 28, 2023 and will end on September 15, 2023 (terms included and subject to extension). The payment of the consideration for the shares that will be sold in compliance with the sell-out procedure during the period, equal to 9.96 euros per share, will take place on 22 September 2023.